101612 Federal Register / Vol. 89, No. 241 / Monday, December 16, 2024 / Notices 

Address: National Institutes of Health 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Meeting Format: Virtual Meeting. 

Contact Person: Andrea B. Kelly, Ph.D., 

Scientific Review Officer, National Institute 

on Deafness and Other Communication 

Disorders, National Institutes of Health, 6001 

Executive Boulevard, Room 8351, Bethesda, 

MD 20892, (301) 451–6339, kellya2@nih.gov. 

Name of Committee: Communication 

Disorders Review Committee. 

Date: February 20–21, 2025. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: Hilton Garden Inn Orlando at 

SeaWorld Orlando, FL. 

Meeting Format: In Person and Virtual 

Meeting. 

Contact Person: Katherine Shim, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, NIDCD, NIH, 6001 

Executive Blvd., Bethesda, MD 20892, 301– 

496–8683, shimk@nidcd.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: December 11, 2024. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–29558 Filed 12–13–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting of the National 

Institute of Biomedical Imaging and 

Bioengineering Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; P41 NCBIB Review 

D–SEP. 

Date: March 4–7, 2024. 

Time: 9:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Democracy II, Suite 920, 6707 Democracy 

Blvd., Bethesda, MD 20817 (Virtual Meeting). 

Contact Person: John Hayes, Ph.D., 

Scientific Review Officer, National Institute 

of Biomedical Imaging and Bioengineering, 

National Institutes of Health, 6707 

Democracy Blvd., Bethesda, MD 20892, (301) 

451–3398, john.hayes@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, National Institute of 

Biomedical Imaging and Bioengineering, 

National Institutes of Health.) 

Dated: December 11, 2024. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–29551 Filed 12–13–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Trial Net Hub and 

Coordinating Center Cooperative Agreement 

(U01) Application Review. 

Date: February 28, 2025. 

Time: 12:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

National Institute of Diabetes and Digestive 

and Kidney Diseases, Democracy II, Suite 

7000A, 6707 Democracy Boulevard, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Cheryl Nordstrom, Ph.D., 

MPH, Scientific Review Officer, Scientific 

Review Branch, National Institute of Diabetes 

and Digestive and Kidney Diseases, National 

Institutes of Health, 6707 Democracy 

Boulevard, Room 7013, Bethesda, MD 20892, 

301–402–6711, cheryl.nordstrom@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: December 11, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–29540 Filed 12–13–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting. 

The meeting will be open to the 

public as indicated below. Individuals 

who plan to attend and need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations should notify the 

Contact Person listed below in advance 

of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), title 5 U.S.C., as amended for 

review, discussion, and evaluation of 

individual intramural programs and 

projects conducted by the National 

Library of Medicine, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Library of 

Medicine Board of Scientific Counselors. 

Date: April 30, 2025. 

Open: 9:00 a.m. to 10:20 p.m. 

Agenda: Program Discussion and 

Investigator Report. 

Closed: 10:20 p.m. to 11:45 a.m. 

Agenda: To review and evaluate personal 

qualifications, performance, and competence 

of individual investigators. 

Open: 11:45 a.m. to 12:30 p.m. 

Agenda: Program Discussion and 

Investigator Report. 

Closed: 12:30 p.m. to 2:00 p.m. 

Agenda: To review and evaluate personal 

qualifications, performance, and competence 

of individual investigators. 

Open: 2:00 p.m. to 2:45 p.m. 

Agenda: Program Discussion and 

Investigator Report. 

Place: National Library of Medicine, 8600 

Rockville Pike, Bethesda, MD 20892 (Inperson and Virtual Meeting). 


lotter on DSK11XQN23PROD with NOTICES1